The Use of Ligasure (r) for Hydrocelectomy Surgery
The Use of Ligasure (r) for Cutting and Coagulations of Tissues in Hydrocelectomy Surgery
1 other identifier
interventional
61
1 country
1
Brief Summary
Hydrocele is a condition of fluid retention around the testes, which causes swallowing, pain, with interfering with the normal testes function. however, during activity, this can interfere with everyday activity (running, sexual intercourse). The treatment for hydrocele I surgical. The study aim to test the safety and efficacy of the Ligasure (r) device for cutting and coagulating tissues during hydrocelectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedFirst Submitted
Initial submission to the registry
May 6, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedMay 28, 2020
May 1, 2020
1.9 years
May 6, 2020
May 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
resolution of hydrocele
The patients will undergo full urological physical exam to screen for signs of hydrocele. The testes size and manual palpation will be included in the assessment.
Three weeks after the surgery
Study Arms (1)
Intervention
EXPERIMENTALPatients suffering from hydrocele, underwent treatment using Ligasure device.
Interventions
Eligibility Criteria
You may qualify if:
- males
- Diagnosed with unilateral hydrocele
You may not qualify if:
- Bilateral hydrocele
- infected hydrocele
- hydrocele secondary to tumor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hillel Yaffe MC,
Hadera, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2020
First Posted
May 28, 2020
Study Start
February 18, 2018
Primary Completion
December 30, 2019
Study Completion
December 30, 2019
Last Updated
May 28, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share